Enhanced plasma levels of LIGHT in patients with acute atherothrombotic stroke

Acta Neurologica Scandinavica

Volumn 118, Issue 4, 2008, Pages 256-259

  Liu, G Z ^a   Fang, L B ^b   Hjelmstrom, P ^c   Gao, X G ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Atherogenesis; Ischemic atherosclerotic stroke; LIGHT; Peripheral blood

Indexed keywords

HERPESVIRUS ENTRY MEDIATOR LIGAND;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CHINESE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PROTEIN DETERMINATION; STROKE; THROMBOCYTE COUNT; THROMBOSIS;

AGED; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; PLATELET COUNT; RISK FACTORS; STROKE; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

EID: 51349149782     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01013.x     Document Type: Article

References (17)

1. Elkind MSV. Inflammation, atherosclerosis and stroke. Neurologist 2006 12 : 140 8.
2. Libby P. Inflammation in atherosclerosis. Nature 2002 420 : 868 74.
3. Bednar MM, Gross CE. Antiplatelet therapy in acute cerebral ischemia. Stroke 1999 30 : 887 93.
4. Young JL, Libby P, Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 2002 88 : 554 67.
5. Aukrust P, Muller F, Ueland T et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999 100 : 614 20.
6. Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res 2001 89 : 1092 103.
7. Lee WH, Kim SH, Lee Y et al. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol 2001 21 : 2004 10.
8. Otterdal K, Smith C, Oie E et al. Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes. Blood 2006 108 : 928 35.
9. Chang YH, Hsieh SL, Chao Y, Chou YC, Lin WW. Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells. J Biomed Sci 2005 12 : 363 75.
10. Scholz H, Sandberg W, Damas JK et al. Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis. Circulation 2005 112 : 2121 9.
11. Celik S, Langer H, Stellos K et al. Platelet-associated LIGHT (TNFSF14) mediates adhesion of platelets to human vascular endothelium. Thromb Haemost 2007 98 : 798 805.
12. Adams HP Jr., Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993 24 : 35 41.
13. Cohavy O, Zhou J, Ware CF, Targan SR. LIGHT is constitutively expressed on T and NK cells in the human gut and can be induced by CD2-mediated signaling. J Immunol 2005 174 : 646 53.
14. Schneider K, Potter KG, Ware CF. Lymphotoxinand LIGHT signaling pathways and target genes. Immunol Rev 2004 202 : 49 66.
15. Otterdal K, Pedersen TM, Solum NO. Release of soluble CD40 ligand after platelet activation. Studies on the solubilization phase. Thromb Res 2004 114 : 167 77.
16. Furman MI, Krueger LA, Linden MD, Barnard MR, Frelinger AL, Michelson AD. Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. J Am Coll Cardiol 2004 43 : 2319 25.
17. Nannizzi-Alaimo L, Alves VL, Phillips DR. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation. Circulation 2003 107 : 1123 8.